Curtis Hose

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.2K citations

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

J S Lee, K Paull, Curtis Hose et al. · Molecular Pharmacology · 1994 · 339 citations

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.

Mauricio Muleiro Álvarez, K Paull, A Monks et al. · Journal of Clinical Investigation · 1995 · 218 citations · Full text

Drug Target, Quantitative Pcr, Cancer Biology +16

Cediranib for Metastatic Alveolar Soft Part Sarcoma

Shivaani Kummar, Deborah Allen, Anne Monks et al. · Journal of Clinical Oncology · 2013 · 217 citations

The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.

Craig P. Webb, Curtis Hose, Shahriar Koochekpour et al. · PubMed · 2000 · 168 citations

Pharmaceutical Science, Chemoprevention Strategy, Cellular Pharmacology +22